Extracranial carotid disease accounts for approximately 25% of ischemic strokes. Although carotid endarterectomy (CEA) is the established gold standard for carotid revascularization, carotid artery angioplasty and stenting (CAS) is continually developing into a safer and more efficacious method of stroke prevention and has gained popularity as an alternative to CEA. Recent trials have reported clinical equipoise between CEA and CAS. There are certain patient characteristics that can increase the risk of adverse outcomes for both CEA and CAS. Proper patient selection is the key to successful outcomes when deciding the optimal treatment for carotid stenosis. Patients must be individualized, and a specific risk—benefit ratio must be formulated for CEA, CAS, and best-medical therapy (BMT). Ultimately, optimizing medical therapy and using CEA and CAS as complementary therapies rather than competing ones will likely achieve the best patient outcomes.
Prati P., Vanuzzo D., Casaroli M., et al. Prevalence and determinants of carotid atherosclerosis in a general population. Stroke. 1992;23:1705-1711.
4.
Edwards WH, Morris JA Jr, Jenkins JM, Bass SM, MacKenzie EJEvaluating quality, cost-effective health care: vascular database predicated on hospital discharge abstracts. Ann Surg. 1991;213:433-438; discussion 8-9.
5.
Theiss W., Hermanek P., Mathias K., et al. Predictors of death and stroke after carotid angioplasty and stenting: a subgroup analysis of the Pro-CAS data. Stroke . 2008;39:2325-2330.
6.
Fiehler J., Jansen O., Berger J., Eckstein HH, Ringleb PA, Stingele R.Differences in complication rates among the centres in the SPACE study. Neuroradiology. 2008;50:1049-1053.
7.
Alberts MJResults of a multicenter prospective randomized trial of carotid artery stenting vs carotid endarterectomy. Stroke. 2001;32:325.
8.
Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis.North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1991;325:445-453.
9.
Endarterectomy for asymptomatic carotid artery stenosis.Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995;273:1421-1428.
10.
Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351:1379-1387.
11.
Halliday A. , Mansfield A., Marro J., et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet. 2004;363:1491-1502.
12.
Sillesen H. , Amarenco P., Hennerici MG, et al. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial . Stroke. 2008;39:3297-3302.
13.
Harker LA, Boissel JP, Pilgrim AJ, Gent M.Comparative safety and tolerability of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events. Drug Saf. 1999;21:325-335.
14.
Sacco RL, Adams R., Albers G., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation. 2006;113:e409-e449.
15.
Hobson RW II , Mackey WC, Ascher E., et al. Management of atherosclerotic carotid artery disease: clinical practice guidelines of the Society for Vascular Surgery . J Vasc Surg. 2008;48:480-486.
16.
Biller J., Feinberg WM, Castaldo JE, et al. Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation. 1998;97:501-509.
17.
Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet. 2001 ;357:1729-1737.
18.
Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351:1493-1501.
19.
Gurm HS, Yadav JS, Fayad P., et al. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med. 2008;358:1572-1579.
20.
Carotid revascularization using endarterectomy or stenting systems (CARESS): phase I clinical trial. J Endovasc Ther . 2003;10:1021-1030.
21.
Ringleb PA, Allenberg J., Bruckmann H., et al. 30 Day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet. 2006; 368:1239-1247.
22.
Mas JL, Chatellier G., Beyssen B., et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006 ;355:1660-1671.
23.
Coward LJ, Featherstone RL, Brown MMSafety and efficacy of endovascular treatment of carotid artery stenosis compared with carotid endarterectomy: a Cochrane systematic review of the randomized evidence. Stroke. 2005;36: 905-911.
24.
Hopkins LN, Myla S., Grube E., et al. Carotid artery revascularization in high surgical risk patients with the NexStent and the Filterwire EX/EZ: 1-year results in the CABER-NET trial. Catheter Cardiovasc Interv. 2008;71:950-960.
25.
Gray WA, Hopkins LN, Yadav S., et al. Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J Vasc Surg. 2006;44:258-268.
26.
Safian RD, Jaff MR, Bresnahan JF, et al. Protected carotid stenting in high-risk patients: results of the SpideRX arm of the Carotid Revascularization with ev3 Arterial Technology Evolution Trial [published online ahead of print July 8, 2010]. J Interv Cardiol doi: 10.1111 j.1540-8183.2010.00578.x.
27.
Fairman R., Gray WA, Scicli AP, et al. The CAPTURE registry: analysis of strokes resulting from carotid artery stenting in the post approval setting: timing, location, severity, and type. Ann Surg. 2007;246:551-556; discussion 556-558.
28.
White CJ, Iyer SS, Hopkins LN, Katzen BT, Russell MECarotid stenting with distal protection in high surgical risk patients: the BEACH trial 30 day results. Catheter Cardiovasc Interv. 2006;67:503-512.
29.
Katzen BT, Criado FJ, Ramee SR, et al. Carotid artery stenting with emboli protection surveillance study: thirty-day results of the CASES-PMS study. Catheter Cardiovasc Interv. 2007;70:316-323.
30.
Brott TG, Hobson RW II, Howard G., et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363(1):11-23.
31.
International Carotid StentingStudy Investigators; Ederle J., Dobson J., Featherstone RL, et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial. Lancet. 2010;375:985-997.
32.
Goldstein LB, McCrory DC, Landsman PB, et al. Multicenter review of preoperative risk factors for carotid endarterectomy in patients with ipsilateral symptoms. Stroke . 1994;25:1116-1121.
33.
Mozes G., Sullivan TM, Torres-Russotto DR, et al. Carotid endarterectomy in SAPPHIRE-eligible high-risk patients: implications for selecting patients for carotid angioplasty and stenting. J Vasc Surg. 2004;39:958-965; discussion 965-966.
34.
Illig KA, Zhang R., Tanski W., Benesch C., Sternbach Y., Green RMIs the rationale for carotid angioplasty and stenting in patients excluded from NASCET/ACAS or eligible for ARCHeR justified? J Vasc Surg. 2003;37:575-581.
35.
Hassen-Khodja R., Sala F., Declemy S., Lagrange JL, Bouillane PJ, Batt M.Surgical management of atherosclerotic carotid artery stenosis after cervical radiation therapy. Ann Vasc Surg. 2000;14:608-611.
36.
AbuRahma AF , Jennings TG, Wulu JT, Tarakji L., Robinson PARedo carotid endarterectomy versus primary carotid endarterectomy. Stroke. 2001;32:2787-2792.
Carotid Stenting Guidelines Committee, Bladin C., Chambers B., New G., Denton M., Lawrence-Brown M.Guidelines for patient selection and performance of carotid artery stenting . ANZ J Surg. 2010;80:398-405.
39.
Tedesco MM, Coogan SM, Dalman RL, et al. Risk factors for developing postprocedural microemboli following carotid interventions. J Endovasc Ther. 2007 ;14:561-567.
40.
Flach HZ, Ouhlous M., Hendriks JM, et al. Cerebral ischemia after carotid intervention. J Endovasc Ther. 2004;11: 251-257.
41.
Barnett HJ, Meldrum HE, Eliasziw M.The appropriate use of carotid endarterectomy. CMAJ. 2002;166:1169-1179.
42.
Gonzalez A. , Mayol A., Gil-Peralta A., Gonzalez-Marcos JR, Boza F., Ruano J.Angioplasty of symptomatic high-grade internal carotid artery stenosis with intraluminal thrombus: therapeutic approach. Neuroradiology. 2004;46:313-317.
43.
Tsumoto T., Terada T., Tsuura M., et al. Carotid artery stenting for stenosis with intraluminal thrombus . Neuroradiology. 2006;48:54-59.
44.
Goodney PP, Likosky DS, Cronenwett JLFactors associated with stroke or death after carotid endarterectomy in Northern New England. J Vasc Surg. 2008;48:1139-1145.
45.
O’Hara PJ, Hertzer NR, Mascha EJ, Beven EG, Krajewski LP, Sullivan TMCarotid endarterectomy in octogenarians: early results and late outcome. J Vasc Surg. 1998 ;27:860-869; discussion 870-871.
46.
Bacharach JM , Slovut DP, Ricotta JJ, Sullivan TMOctogenarians are not at increased risk for periprocedural stroke following carotid artery stenting. Ann Vasc Surg. 2010;24: 153-159.
47.
Ricotta JJ, Malgor R., Sullivan TMThirty day outcomes for carotid intervention performed by vascular surgeon at a single institution who perform both carotid endarterectomy and carotid artery stenting. MidWest Vascular Surgery Society, Abstract Book 2008: p.15.
